ArticleJournal of the Chinese Medical Association : JCMA2021

Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma.

Yi-Ping Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.